Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Gores Guggenheim Stock Is Banking on the Wrong Car at the Wrong Time

While GGPI stock is among many investments in the exciting electric vehicle space, economic dynamics present an awkward headwind.

Peloton’s Comeback Will Be an Uphill Climb

PTON stock soared this week. However, its comeback will take a lot longer to pull off, if it manages to bounce back at all.

Investors Should Avoid Robinhood Stock At All Costs

Robinhood’s stock-based compensation is too high and its crypto plans may prove a distraction, prompting a further decline in HOOD stock.

QuantumScape Is a Case Study on Theory Vs. Reality

QS stock has no key factors that indicate it could rise soon. All of their momentum hinges on news that's over 2 years away.

Matterport Stock May Be Bottoming, But It Remains Risky

MTTR stock may have found a near-term floor in the high single digits, but its price could easily drop much further.

Digital World Acquisition Could Fall Post Merger Due To Numerous Risks with TMTG

DWAC stock could take a big tumble post-merger based on dilution, valuation, and key-man risks associated with SPAC merger with TMTG.

You Won’t Be Striking Oil Investing in Camber Energy

Camber Energy is stuck in a rut and its clean energy efforts are unlikely to amount to very much for CEI stock.

Block Faces Tough Competition and an Uncertain Future

Block faces a number of challenges in a market that's less than thrilled with the digital payments sector and SQ stock.

AMC’s Bond Deal: The Good, the Bad and the Ugly

AMC stock has generally been weak lately. The company's latest bond offering won't change that, even though the funds will be helpful.

With No Vaccine Approval, Ocugen Is the Definition of Dead Money

Holding out hope for a Covid vaccine approval that might never come, OCGN stock is too risky while the company has no revenue.

Peloton Stock Still Has No Place in a Legitimate Growth Portfolio

Peloton’s big week continues the day after PTON stock popped on acquisition rumors, with CEO cut and big layoffs.

7 Russian Stocks at Risk of Being Roiled By the Ukraine Conflict

Russia is flexing its military muscle once again. This could put these seven Russian stocks in serious jeopardy.

Grab Stock Is Not a Good Name to Latch Onto

Investors should look for plays with less competition and more favorable markets than Grab. And Grab stock has just too high of a valuation.

A Buyout May Be the Best Hope for Clover Health Now

The situation behind CLOV stock is spiraling from bad to worse. A sale of the company may be the only option to keep Clover Health running.

The ‘Discounted’ Price in NIO Stock Is a Lie

NIO stock continues to have key risks that do not make it a hot buy now. Its valuation remains too rich, and the firm continues to lose money.

StoneCo Stock Has Room to Fall Before it Hits Rock Bottom

Expect the market to carry on sending STNE stock to lower prices. With no need to jump in, taking a hard pass on it is your best move.

GameStop’s NFT Pivot Is an Act of Desperation, Not Innovation

GME stock is changing as the company is pivoting into NFTs, not that investors should care. It's still one to skip.

Is Beyond Meat Stock Beyond Help?

Beyond Meat continues to attract big partnerships and positive analyst coverage despite the poor performance of BYND stock.

Investors Have Cast Their ‘No’ Votes Against Bionano Genomics

A preliminary report from Bionano Genomics doesn't tell the full story and a lack of profitability will likely weigh on BNGO stock.